85 related articles for article (PubMed ID: 22964333)
1. Identification of Max binding protein as a novel binding protein of Nck1 and characterization of its role in inhibiting human liver cancer SK-HEP-1 cells.
Zhou Q; Huang T; Wang YF; Zhang KS; Chen D; Peng BG
Chin Med J (Engl); 2012 Sep; 125(18):3336-9. PubMed ID: 22964333
[TBL] [Abstract][Full Text] [Related]
2. MNT inhibits the migration of human hepatocellular carcinoma SMMC7721 cells.
Wu J; Zhou Q; Wang Y; Zhou X; Li J
Biochem Biophys Res Commun; 2012 Feb; 418(1):93-7. PubMed ID: 22244890
[TBL] [Abstract][Full Text] [Related]
3. Identification of Dermcidin as a novel binding protein of Nck1 and characterization of its role in promoting cell migration.
Shen SL; Qiu FH; Dayarathna TK; Wu J; Kuang M; Li SS; Peng BG; Nie J
Biochim Biophys Acta; 2011 Jun; 1812(6):703-10. PubMed ID: 21397687
[TBL] [Abstract][Full Text] [Related]
4. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
[TBL] [Abstract][Full Text] [Related]
5. Of Myc and Mnt.
Hooker CW; Hurlin PJ
J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
[TBL] [Abstract][Full Text] [Related]
6. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome.
Toyo-oka K; Hirotsune S; Gambello MJ; Zhou ZQ; Olson L; Rosenfeld MG; Eisenman R; Hurlin P; Wynshaw-Boris A
Hum Mol Genet; 2004 May; 13(10):1057-67. PubMed ID: 15028671
[TBL] [Abstract][Full Text] [Related]
8. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
9. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.
Kapoor I; Kanaujiya J; Kumar Y; Thota JR; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Oncotarget; 2016 Feb; 7(7):7640-56. PubMed ID: 26506232
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.
Dezfouli S; Bakke A; Huang J; Wynshaw-Boris A; Hurlin PJ
Mol Cell Biol; 2006 Mar; 26(6):2080-92. PubMed ID: 16507988
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
12. Detection of tyrosine‑phosphorylated proteins in hepatocellular carcinoma tissues using a combination of GST‑Nck1‑SH2 pull‑down and two‑dimensional electrophoresis.
Qiu F; Huang D; Xiao H; Qiu F; Lu L; Nie J
Mol Med Rep; 2013 Apr; 7(4):1209-14. PubMed ID: 23426619
[TBL] [Abstract][Full Text] [Related]
13. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
14. Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity.
Ger M; Zitkus Z; Valius M
Cell Signal; 2011 Oct; 23(10):1651-8. PubMed ID: 21664272
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
[TBL] [Abstract][Full Text] [Related]
16. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
18. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
19. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
Larsson LG; Bahram F; Burkhardt H; Lüscher B
Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]